K. Toyama

Tumor long-axis diameter and SUVmax predict long-term responders in 90Y-ibritumomab tiuxetan monotherapy

Y. Tsushima, M. Matsumoto, T. Higuchi, 2018, International Journal of Hematology.

Low burden of a JAK2-V617F mutated clone in monoclonal haematopoiesis in a Japanese woman with Budd-Chiari syndrome

S. Miyawaki, H. Takagi, Arito Yamane, 2009, International journal of hematology.

JAK2‐V617F mutation analysis of granulocytes and platelets from patients with chronic myeloproliferative disorders: advantage of studying platelets

S. Miyawaki, Arito Yamane, Y. Nojima, 2007, British journal of haematology.

Clinical management and outcomes of completely resected stage I follicular lymphoma.

M. Kojima, M. Matsumoto, Y. Nojima, 2018, Journal of clinical and experimental hematopathology : JCEH.

Polycythemia Vera Terminating in Refractory Ascites

Y. Nojima, H. Handa, M. Sakuraya, 2012 .

Differences in the JAK2 and MPL mutation status in the cell lineages of the bcr/abl-negative chronic myeloproliferative neoplasm subtypes.

Y. Nojima, H. Handa, N. Tsukamoto, 2011, Internal medicine.

Prognostic impact of trisomy 21 in follicular lymphoma

M. Kojima, M. Matsumoto, H. Handa, 2018, British journal of haematology.

Successful treatment with reduced-intensity stem cell transplantation for secondary myelofibrosis following polycythemia vera.

Y. Nojima, H. Handa, N. Tsukamoto, 2009, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Circulating plasmacytoid dendritic cells in patients with primary and Helicobacter pylori‐associated immune thrombocytopenia

H. Nakahashi, Y. Nojima, Y. Ogawa, 2012, European journal of haematology.